Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study

Respiratory Medicine

Volumn 104, Issue 1, 2010, Pages 67-75

  Soler, Néstor ^a,b   Ballester, Eugeni ^a,b   Martín, Antonio ^c   Gobartt, Elena ^d   Miravitlles, Marc ^a,b   Torres, Antoni ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c PFIZER INC   (United States)

^d Boehringer Ingelheim SCV   (Spain)

Author keywords

Chronic Obstructive Pulmonary Disease (COPD); Diagnosis and Management; Primary Health Care; Spanish Guidelines; Spirometry

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HUMAN; MEDICAL SOCIETY; PATIENT CODING; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPAIN; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT PLANNING;

ADULT; FAMILY PRACTICE; FEMALE; FORCED EXPIRATORY VOLUME; GUIDELINE ADHERENCE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; SPAIN; SPIROMETRY;

EID: 74049085058     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.08.003     Document Type: Article

References (36)

1. Pouwels R., Buist S., Calverley P., Ch J., Hurd S., and on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 163 (2001) 1256-1576
2. Sobradillo V., Miravitlles M., Gabriel R., et al. Geographic variations in prevalence and underdiagnosis of COPD: results of IBERCOP multicentre epidemiological study. Chest 118 (2000) 881-989
3. Barberà J.A., Peces-Barba G., Agustí A.G.N., et al. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease. Arch Bronconeumol 37 (2001) 297-316
4. Miravitlles M., De la Roza C., Morera J., et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respi Med 100 (2006) 1973-1980
5. De Miguel J., Izquierdo J.L., Rodríguez-González J.M., et al. Reliability of chronic obstructive disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol 39 (2003) 195-202
6. Clotet J., Gómez-Arbonés X., Ciria C., et al. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol 40 (2004) 155-159
7. Bednarek M., Maciejewski J., Wozniak M., et al. Prevalence, severity, and under-diagnosis of COPD in primary care setting. Online First. Thorax (January 30, 2008) 10.1136/thx.2007.085456
8. Walker P.P., Mitchell P., Diamantea F., et al. Effect of primary-care spirometry o the diagnosis and management of COPD. Eur Respir J 28 (2006) 945-952
9. Zaas D., Wise R., and Wiener C. Airway obstruction is common but unsuspected in patients admitted to a general medicine service. Chest 125 (2004) 106-111
10. Buffels J., Degryse J., Heyrman J., et al. Office spirometry significant improves early detection of COPD in general practice. The DIDASCO study. Chest 125 (2004) 1394-1399
11. Derom E., Veel V., Liistro G., et al. Primary care spirometry. Eur Respir J 31 (2008) 197-2003
12. Lusuardi M., De Benedetto F., Paggiaro P., et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: a comparative evaluation in Italian study. Chest 129 (2006) 844-852
13. Walters J.A., Hansen E.C., Haydn W., and Wood-Baker R. Under-diagnosis of chronic pulmonary disease: a qualitative study in primary care. Respir Med 102 5 (2008) 738-743
14. Schermer T.R., Jacobs J.E., Chavannes N.H., et al. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 58 (2003) 861-866
15. Walkers J.A., Hansen E.C., Johns D.P., et al. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of Chronic Obstructive Pulmonary Disease (COPD). Online First. Thorax (December 5, 2007) 10.1136/thx.2007.082659
16. 6. Eur Respir J (2006) 378-383
17. 6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 27 (2006) 374-377
18. Lamprecht B., Schirnhofer L., Tiefenbacher F., et al. Six-second spirometry for detection airway obstruction. Am J Respir Crit Care Med 176 (2007) 460-464
19. Fergusson G.T., Enright P., Buist S., and Higgins M. Office spirometry for lung health assessment in adults. Chest 117 (2000) 1146-1161
20. Roca J., Burgos F., Sunyer J., et al. References values for forced spirometry. Eur Respir J 11 (1998) 1354-1362
21. Izquierdo J.L., Rodriguez-González J.M., de Lucas P., et al. Has the treatment of COPD changed in Spain? Results of a community study (VICE). Rev Clin Esp 1 (2008) 18-25
22. Smith C.J., Gribbin J., Challen K.B., and Hubbard R.B. The impact of the 2004 NICE guideline and 2003 general medical services contract on COPD in primary care in UK. QJM 101 (2008) 145-153
23. 1/FVC and FVC in the spirometric detection for airway obstruction and restriction. Chest 127 (2005) 1560-1564
24. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 162 (2000) 917-919
25. Swanney M.P., Beckert L.E., Frampton C.M., et al. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. Chest 26 (2004) 1861-1866
26. Miller M.R., Hankinson J., Brusasco V., et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
27. Hansen J.E., Sun X.C., and Wasserman K. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?. Eur Respir J 27 (2006) 1244-1250
28. Bolton C.E., Ionescu A., Edwards P., et al. Attaining a correct diagnosis of COPD in general practice. Respir Med 99 (2005) 493-500
29. Lucas A.E., Smeenk F.W., Smeele I.J., and van Schayck C.P. Over-treatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Advanced published. Fam Pract (February 27, 2008) 1-6
30. Van der Boom G., Van Schayck C.P., Van Möllén M.P., et al. Active detection of chronic pulmonary disease and asthma in the general population: results and economic consequences of the DIMCA program. Am J Respir Crit Care Med 158 (1998) 1730-1738
31. Burge P.S. EUROSCOP, ISOLDE and the Copenhagen city lung study. Thorax 54 (1999) 287-288
32. Donohue J.F., Van Noord J., Bateman E.D., et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 122 (2002) 47-55
33. Rudolf M. The reality of drug use in COPD. The European perspective. Chest 117 (2000) 29S-32S
34. Dales R.E., Vandemheen K., Clinch J., et al. Spirometry in the primary care setting. Influence on clinical diagnosis and management of airflow obstruction. Chest 128 (2005) 2443-2447
35. Hilleman D.E., Dewan N., Malesker M., et al. Pharmacoeconomic evaluation of COPD. Chest 118 (2000) 1278-1285
36. Wise R.A., and Tashkin D.P. Optimizing treatment of obstructive pulmonary disease: an assessment of current therapies. Am J Med 120 (2007) S4-S13